Restricted accessCase reportFirst published online 2022-3
Biallelic Mutations in Ubiquitin-Specific Peptidase 53 ( USP53 ) Causing Progressive Intrahepatic Cholestasis. Report of a Case With Review of Literature
Whole-exome sequencing studies have recently identified novel genes implicated in normal- or low-GGT pediatric cholestasis including ubiquitin-specific peptidase 53 (USP53). We identified novel biallelic mutations in the USP53 gene in a 7-month-old infant with pruritus and progressive intrahepatic cholestasis. His liver biopsy showed portal and perivenular fibrosis with bland bilirubinostasis. His parents were asymptomatic heterozygous for the same mutation. He is currently on vitamin supplements and cholestyramine and his family has also been counseled for liver transplantation. Our report confirms that patients with biallelic mutation in USP53 develop cholestatic liver disease.
VijMSafwanMShanmugamNPRelaM. Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases. Ann Diagn Pathol. 2015;19(5):277-282.
ValamparampilJJReddyMSShanmugamNVijMKanagaveluRGRelaM. Living donor liver transplantation in alagille syndrome-Single center experience from south Asia. Pediatr Transplant. 2019;23(8):e13579.
7.
OudMMLamersIJArtsHH. Ciliopathies: genetics in pediatric medicine. J Pediatr Genet. 2017;6(1):18-29.
8.
HeubiJESetchellKDRBoveKE. Inborn errors of bile acid metabolism. Clin Liver Dis. 2018;22(4):671-687.
9.
GonzalesETaylorSADavit-SpraulA, et al. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusiondisease. Hepatology. 2017;65(1):164-173.
10.
VijMShanmugamNPReddyMSSankaranarayananSRelaM. Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency. Virchows Arch. 2017;471(5):679-683.
11.
ChenHLWuSHHsuSHLiouBYChenHLChangMH. Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases. J Biomed Sci. 2018;25(1):75.
ZhangJYangYGongJY, et al. Low-GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization. Liver Int. 2020;40(5):1142-1150.
14.
MaddirevulaSAlhebbiHAlqahtaniA, et al. Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants. Genet Med. 2019;21(5):1164-1172.
15.
QuesadaVDíaz-PeralesAGutiérrez-FernándezAGarabayaCCalSLópez-OtínC. Cloning and enzymatic analysis of 22 novel human ubiquitin-specific. Biochem Biophys Res Commun. 2004;314(1):54-62.
16.
HuMLiPLiM, et al. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2002;111(7):1041-1054.
17.
KazmierczakMHarrisSLKazmierczakP, et al. Progressive hearing loss in mice carrying a mutation in Usp53. J Neurosci. 2015;35(47):15582-15598.
18.
AlhebbiHPeer-ZadaAAAl-HussainiAA, et al. New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin. J Hum Genet. 2021;66(2):151-159.
19.
FuruseMFujitaKHiiragiTFujimotoKTsukitaS. Claudin-1 and -2: novelintegral membrane proteins localizing at tight junctions with no sequencesimilarity to occludin. J Cell Biol. 1998;141(7):1539-1550.
SambrottaMStrautnieksSPapouliEUniversity of Washington Center for Mendelian GenomicsSmithJDJohnsonCAMcCleanP, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014;46(4):326-328.
22.
WalshTPierceSBLenzDR, et al. Genomic duplication and overexpression ofTJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51. Am J Hum Genet. 2010;87(1):101-109.
23.
PortaGRigoPSMPortaA, et al. Progressive familial intrahepatic cholestasis associated with USP53 gene mutation in a Brazilian child. J Pediatr Gastroenterol Nutr. 2021;72(5):674-676.
24.
BullLNEllmersRFoskettP, et al. Cholestasis due to USP53 deficiency. J Pediatr Gastroenterol Nutr. 2021;72(5):667-673.
25.
PawlikowskaLGroenAEppensEF, et al. A mouse genetic model forfamilial cholestasis caused by ATP8B1 mutations reveals perturbed bile salthomeostasis but no impairment in bile secretion. Hum Mol Genet. 2004;13(8):881-892.
26.
GroenAKunneCPaulusmaCC, et al. Intestinal bile salt absorption in Atp8b1 deficient mice. J Hepatol. 2007;47(1):114-122.
